Targeted genome editing by lentiviral protein transduction of zinc-finger and TAL-effector nucleases
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted genome editing by lentiviral protein transduction of zinc-finger and TAL-effector nucleases
Authors
Keywords
-
Journal
eLife
Volume 3, Issue -, Pages -
Publisher
eLife Sciences Publications, Ltd
Online
2014-04-24
DOI
10.7554/elife.01911
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrase-defective Lentiviral Vectors as a Delivery Platform for Targeted Modification of Adenosine Deaminase Locus
- (2013) Alok V Joglekar et al. MOLECULAR THERAPY
- Targeted Gene Addition in Human Epithelial Stem Cells by Zinc-finger Nuclease-mediated Homologous Recombination
- (2013) Andrea Coluccio et al. MOLECULAR THERAPY
- Genomic Editing of the HIV-1 Coreceptor CCR5 in Adult Hematopoietic Stem and Progenitor Cells Using Zinc Finger Nucleases
- (2013) Lijing Li et al. MOLECULAR THERAPY
- DNA transposition by protein transduction of the piggyBac transposase from lentiviral Gag precursors
- (2013) Yujia Cai et al. NUCLEIC ACIDS RESEARCH
- Receptor-mediated delivery of engineered nucleases for genome modification
- (2013) Zhong Chen et al. NUCLEIC ACIDS RESEARCH
- Optimization of scarless human stem cell genome editing
- (2013) Luhan Yang et al. NUCLEIC ACIDS RESEARCH
- ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
- (2013) Thomas Gaj et al. TRENDS IN BIOTECHNOLOGY
- Zinc-finger nuclease-mediated gene correction using single AAV vector transduction and enhancement by Food and Drug Administration-approved drugs
- (2012) B L Ellis et al. GENE THERAPY
- Optimized TAL effector nucleases (TALENs) for use in treatment of sickle cell disease
- (2012) Ning Sun et al. Molecular BioSystems
- In vivo genome editing using a high-efficiency TALEN system
- (2012) Victoria M. Bedell et al. NATURE
- Targeted gene knockout by direct delivery of zinc-finger nuclease proteins
- (2012) Thomas Gaj et al. NATURE METHODS
- Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells
- (2012) Maarten Holkers et al. NUCLEIC ACIDS RESEARCH
- Development of Transgenic Cloned Pig Models of Skin Inflammation by DNA Transposon-Directed Ectopic Expression of Human β1 and α2 Integrin
- (2012) Nicklas Heine Staunstrup et al. PLoS One
- Enhancing Endosomal Escape of Transduced Proteins by Photochemical Internalisation
- (2012) Kevin Mellert et al. PLoS One
- Efficient TALEN-mediated gene knockout in livestock
- (2012) D. F. Carlson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Potent microRNA suppression by RNA Pol II-transcribed 'Tough Decoy' inhibitors
- (2012) R. O. Bak et al. RNA
- Therapeutic potential of HIV protease-activable CASP3
- (2012) Kosuke Miyauchi et al. Scientific Reports
- Protein transduction by pseudotyped lentivirus-like nanoparticles
- (2011) T Aoki et al. GENE THERAPY
- Comparative Genomic Integration Profiling of Sleeping Beauty Transposons Mobilized With High Efficacy From Integrase-defective Lentiviral Vectors in Primary Human Cells
- (2011) Brian Moldt et al. MOLECULAR THERAPY
- In vivo genome editing restores haemostasis in a mouse model of haemophilia
- (2011) Hojun Li et al. NATURE
- Knockout rats generated by embryo microinjection of TALENs
- (2011) Laurent Tesson et al. NATURE BIOTECHNOLOGY
- Efficient gene targeting mediated by a lentiviral vector-associated meganuclease
- (2011) Araksya Izmiryan et al. NUCLEIC ACIDS RESEARCH
- Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting
- (2011) Tomas Cermak et al. NUCLEIC ACIDS RESEARCH
- TAL Effectors: Customizable Proteins for DNA Targeting
- (2011) A. J. Bogdanove et al. SCIENCE
- Site-specific Gene Insertion Mediated by a Cre-loxP-carrying Lentiviral Vector
- (2010) Gilles Michel et al. MOLECULAR THERAPY
- A TALE nuclease architecture for efficient genome editing
- (2010) Jeffrey C Miller et al. NATURE BIOTECHNOLOGY
- Genome editing with engineered zinc finger nucleases
- (2010) Fyodor D. Urnov et al. NATURE REVIEWS GENETICS
- Targeted chromosomal deletions in human cells using zinc finger nucleases
- (2009) H. J. Lee et al. GENOME RESEARCH
- Production of HIV-1 Integrase Fusion Protein-Carrying Lentiviral Vectors for Gene Therapy and Protein Transduction
- (2009) Diana Schenkwein et al. HUMAN GENE THERAPY
- Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases
- (2009) Dirk Hockemeyer et al. NATURE BIOTECHNOLOGY
- Knockout Rats via Embryo Microinjection of Zinc-Finger Nucleases
- (2009) Aron M. Geurts et al. SCIENCE
- Attenuation of Zinc Finger Nuclease Toxicity by Small-Molecule Regulation of Protein Levels
- (2009) Shondra M. Pruett-Miller et al. PLoS Genetics
- SnapShot: HIV-1 Proteins
- (2008) Chad M. Swanson et al. CELL
- Substitution of the myristoylation signal of human immunodeficiency virus type 1 Pr55Gag with the phospholipase C- 1 pleckstrin homology domain results in infectious pseudovirion production
- (2008) E. Urano et al. JOURNAL OF GENERAL VIROLOGY
- Imaging the biogenesis of individual HIV-1 virions in live cells
- (2008) Nolwenn Jouvenet et al. NATURE
- Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
- (2008) Elena E Perez et al. NATURE BIOTECHNOLOGY
- Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases
- (2008) Yannick Doyon et al. NATURE BIOTECHNOLOGY
- Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases
- (2008) Xiangdong Meng et al. NATURE BIOTECHNOLOGY
- Vpr14-88-Apobec3G Fusion Protein Is Efficiently Incorporated into Vif-Positive HIV-1 Particles and Inhibits Viral Infection
- (2008) Zhujun Ao et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More